Literature DB >> 19030178

TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours.

Tatiana Nedelko1, Volker M Arlt, David H Phillips, Monica Hollstein.   

Abstract

The proposal has been put forward that the primary cause of Balkan endemic nephropathy (BEN) is exposure to food crops contaminated with seeds of Aristolochia spp, which contain high levels of aristolochic acids (AA). Recently, tumour DNA samples from patients with BEN were found to harbour principally A to T mutations in the TP53 tumour suppressor gene (Grollman et al., Proc Natl Acad Sci USA 2007;104:12129-34). Using a novel mutation assay in which we can induce and select mutations in human TP53 sequences in vitro by exposure of cultured cells to a mutagen, we found that A to T mutations were elicited by aristolochic acid at sites in TP53 rarely mutated in human cancers in general, but which were observed in the BEN patients. This concordance of specific mutations in patient tumours and aristolochic acid I-exposed cultures supports the argument that AA has a direct role in the aetiology of BEN-associated cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19030178     DOI: 10.1002/ijc.24006

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  Efficient introduction of specific TP53 mutations into mouse embryonic fibroblasts and embryonic stem cells.

Authors:  Quan-Xiang Wei; Franciscus van der Hoeven; Monica Hollstein; Adam F Odell
Journal:  Nat Protoc       Date:  2012-05-17       Impact factor: 13.491

2.  Upper urinary tract urothelial cancers: where it is A:T.

Authors:  Magali Olivier; Monica Hollstein; Heinz Hans Schmeiser; Kurt Straif; Christopher P Wild
Journal:  Nat Rev Cancer       Date:  2012-08       Impact factor: 60.716

3.  Wild-type and Hupki (human p53 knock-in) murine embryonic fibroblasts: p53/ARF pathway disruption in spontaneous escape from senescence.

Authors:  Catherine Whibley; Adam F Odell; Tatiana Nedelko; Gregor Balaburski; Maureen Murphy; Zhipei Liu; Louisa Stevens; John H Walker; Michael Routledge; Monica Hollstein
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

Review 4.  TP53 mutations in human cancers: origins, consequences, and clinical use.

Authors:  Magali Olivier; Monica Hollstein; Pierre Hainaut
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-01       Impact factor: 10.005

Review 5.  Applications of the human p53 knock-in (Hupki) mouse model for human carcinogen testing.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

6.  A novel p53 mutant found in iatrogenic urothelial cancers is dysfunctional and can be rescued by a second-site global suppressor mutation.

Authors:  Adam F Odell; Luke R Odell; Jon M Askham; Hiba Alogheli; Sreenivasan Ponnambalam; Monica Hollstein
Journal:  J Biol Chem       Date:  2013-04-23       Impact factor: 5.157

7.  Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry.

Authors:  Byeong Hwa Yun; Thomas A Rosenquist; Jovan Nikolić; Dejan Dragičević; Karla Tomić; Bojan Jelaković; Kathleen G Dickman; Arthur P Grollman; Robert J Turesky
Journal:  Anal Chem       Date:  2013-04-10       Impact factor: 6.986

8.  Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.

Authors:  Margaret L Hoang; Chung-Hsin Chen; Viktoriya S Sidorenko; Jian He; Kathleen G Dickman; Byeong Hwa Yun; Masaaki Moriya; Noushin Niknafs; Christopher Douville; Rachel Karchin; Robert J Turesky; Yeong-Shiau Pu; Bert Vogelstein; Nickolas Papadopoulos; Arthur P Grollman; Kenneth W Kinzler; Thomas A Rosenquist
Journal:  Sci Transl Med       Date:  2013-08-07       Impact factor: 17.956

Review 9.  Genomic sequencing in cancer.

Authors:  Musaffe Tuna; Christopher I Amos
Journal:  Cancer Lett       Date:  2012-11-23       Impact factor: 8.679

10.  DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells.

Authors:  Sivaprasad Attaluri; Radha R Bonala; In-Young Yang; Mark A Lukin; Yujing Wen; Arthur P Grollman; Masaaki Moriya; Charles R Iden; Francis Johnson
Journal:  Nucleic Acids Res       Date:  2009-10-23       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.